Ajay Grover
About Ajay Grover
Ajay Grover Labcorp
Ajay Grover holds the title of Co-Discipline Director, Immunology, Flow Cytometry, and Infectious Disease Immunology at Labcorp. His role involves overseeing projects and research related to immunology, specifically in the areas of flow cytometry and infectious disease immunology. His position at Labcorp allows him to contribute significantly to advancements in these fields.
Ajay Grover Education and Expertise
Ajay Grover holds a PhD, which underpins his expertise in Immunology, Flow Cytometry, and Infectious Disease Immunology. His work focuses on the use of NK cell ADCC assays, flow cytometry, and reporter cell lines. His scholarly efforts have contributed to the validation of comprehensive genomic profiling assays and the analysis of immune factors in different types of cancers, including solid tumors and hematologic malignancies.
Ajay Grover Research on Triple Negative Breast Cancer
Ajay Grover has published research on the immunologic factors associated with differential responses to neoadjuvant chemoimmunotherapy in triple negative breast cancer. This research provides insights into how immune factors can influence the effectiveness of treatments, potentially guiding more personalized therapeutic strategies for patients with this aggressive form of cancer.
Ajay Grover Contributions to Liquid Biopsy
Ajay Grover has engaged in pre-analytical characterization of cell-free DNA to enable liquid biopsy for solid tumors. He has analyzed the analytical performance of contrived samples, enhancing the validation of liquid biopsy assays. His work has also focused on improving detection of ctDNA molecular response in immunotherapy-treated non-small cell lung cancer by analyzing cell-free and matched white blood cell DNA.
Ajay Grover Spatial Transcriptomic Analysis
Ajay Grover conducted a spatial transcriptomic study of the tumor microenvironment in head and neck squamous cell carcinoma (HNSCC). This study aims to better understand the complex interactions within the tumor microenvironment, potentially leading to new insights for therapeutic interventions in HNSCC.